GLRX and central nervous system cancer: GLRX was significantly upregulated in the mesenchymal subtype of glioma compared with the other three subtypes in the CGGA (Figure 2A), TCGA (Figure 2C), and CGGA (2019) databases (Supplementary Figure S2A).